Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab
The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
Focusing on logistical matters as it pertains to teplizumab administration, the panel discusses infusion site considerations, insurance coverage hurdles, and the process of getting patients approved.
Teplizumab Infusion Protocol: Details on the 14-Day Process and Comprehensive Monitoring Overview
Diabetes specialists outline the patient selection protocol for teplizumab and describe the teplizumab infusion process.
Exploring Screening and Real-World Use of Teplizumab: Practical Insights and Clinical Experiences
Experts on type 1 diabetes discuss the availability of local medical facilities that offer teplizumab screening and evaluation services for individuals at risk of progression of disease.
TN-10 Study Analysis: Expert Perspectives on Key Efficacy and Safety Data
Amy Burton, MD, reviews findings from the TN-10 study investigating teplizumab, an anti-CD3 monoclonal antibody, for prevention of diabetes in relatives at risk for T1D.
Role of Teplizumab: First Approved Treatment for Delaying T1D Stage Progression
Diabetes experts discuss the important role of teplizumab in delaying the onset of type 1 diabetes and provide insights on the drug’s mechanism of action.
T1D Antibody Screening: Identifying High-Risk Populations
Following audience polls, the panelists provide clinical insights into their screening practices for patients with type 1 diabetes, highlighting key antibodies they screen for.
Engaging the Audience: Polling on Primary Populations and Community Perspectives in T1D Care
Audience polls provide the panel insights into common screening practices for patients with type 1 diabetes.
T1D Staging: The Clinical Importance of Early Recognition
The panel outlines the stages of type 1 diabetes, focusing on the importance of early intervention to prevent complications of the disease.
Navigating T1D: Mitigating Burden and Monitoring Disease Progression
A panel of experts on type 1 diabetes (T1D) describe the prevalence and burden of the disease, highlighting the emotional and socio-economic burden extending beyond medical expenses.